drugset / Trial / NCT03235154

A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic

NCT03235154

NaSingle-groupOpen-labelTreatment

Summary

The main purpose of this pilot study is to investigate the safety, effectiveness and tolerability of the study medication in the treatment of people with chronic hepatitis C virus infection who regularly attend a psychiatrist-staffed clinic for opiate addiction treatment.

Timeline

Start
2017-10-11
Primary completion
2019-09-26
Completion
2019-09-26

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sofosbuvir Small molecule 400 mg
Subject velpatasvir Other / unclassified 100 mg